Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC000213

Drug Information
NameAntalarmin
IndicationDepression
[ICD9: 311   ICD10: F32]
Experimental    
Not AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C24H34N4/c1-9-11-12-27(10-2)23-21-18(6)19(7)28(24(21)26-20(8)2
5-23)22-16(4)13-15(3)14-17(22)5/h13-14H,9-12H2,1-8H3
InChIKeyIXPROWGEHNVJOY-UHFFFAOYSA-N
Canonical SMILESCCCCN(CC)C1=NC(=NC2=C1C(=C(N2C3=C(C=C(C=C3C)C)C)C)C)C    
CAS NumberCAS 157284-96-3
PubChem Compound IDCID 177990.
PubChem Substance IDSID 533085.
TargetCorticotropin releasing factor receptor 1Antagonist[1]
Corticotropin-releasing factor receptor 1Antagonist[2]
Ref 1Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci. 1999;65(4):PL53-8. To Reference
Ref 2A review of drug options in age-related macular degeneration therapy and potential new agents. Expert Opin Pharmacother. 2006 Dec;7(17):2355-68. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543